Sectors With The Most Picks
Biotechnology
| Outperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| VICL | Vical, Inc. | 9/27/2010 | +70.31 |
| EXAS | EXACT Sciences Corp | 4/18/2013 | +36.92 |
| SRPT | Sarepta Therapeutics | 11/12/2012 | +19.18 |
| CYTX | Cytori Therapeutics, Inc. (USA) | 9/6/2011 | +14.34 |
| AFFY | Affymax, Inc. | 10/8/2010 | +13.55 |
| THLD | Threshold Pharmaceuticals, Inc. | 3/28/2013 | +11.25 |
| DNDN | Dendreon Corp | 10/3/2011 | +11.11 |
| PPHM | Peregrine Pharmaceuticals | 9/27/2012 | +11.09 |
| ARNA | Arena Pharmaceuticals, Inc. | 9/14/2010 | +9.71 |
| CBLI | Cleveland BioLabs, Inc. | 11/9/2012 | +8.99 |
| CRIS | Curis, Inc. | 10/1/2010 | +8.81 |
| CYCC | Cyclacel Pharmaceuticals Inc | 9/20/2012 | +8.62 |
| DNDN | Dendreon Corp | 11/4/2011 | +8.29 |
| CLVS | Clovis Oncology | 3/25/2013 | +7.59 |
| QCOR | Questcor Pharmaceuticals | 11/25/2011 | +7.22 |
| AFFY | Affymax, Inc. | 3/28/2012 | +7.19 |
| SQNM | Sequenom, Inc. | 8/14/2012 | +6.21 |
| CHTP | Chelsea Therapeutics International Ltd. | 2/20/2013 | +5.61 |
| ARNA | Arena Pharmaceuticals, Inc. | 8/31/2010 | +5.23 |
| BPAX | Biosante Pharmaceuticals Inc | 8/14/2012 | +4.36 |
| INCY | Incyte Corp | 9/29/2010 | +3.99 |
| ONCY | Oncolytics Biotech, Inc. (USA) | 9/23/2010 | +0.65 |
| PIP | PharmAthene, Inc. | 4/17/2013 | -0.68 |
| PPHM | Peregrine Pharmaceuticals | 2/13/2013 | -9.95 |
| RIGL | Rigel Pharmaceuticals, Inc. | 4/5/2013 | -16.00 |
| CLSN | Celsion Corp | 2/4/2013 | -27.67 |
| MNKD | MannKind Corp | 11/12/2010 | -47.00 |
| AFFY | Affymax, Inc. | 3/5/2013 | -54.16 |
| SVNT | Savient Pharmaceuticals Inc | 3/28/2012 | -92.85 |
| ITMN | InterMune, Inc. | 3/14/2011 | -105.81 |
| WGBS | Wafergen Bio-systems Inc Com | 9/20/2010 | -141.27 |
| Underperform | |||
|---|---|---|---|
| Ticker | Company Name | Pick Date | Score |
| View all Tickers in Tag | |||
| GALE | Galena Biopharma, Inc. | 3/21/2012 | +41.98 |
| CLDX | Celldex Therapeutics, Inc. | 10/5/2010 | +32.41 |
| THLD | Threshold Pharmaceuticals, Inc. | 2/24/2012 | +25.17 |
| QCOR | Questcor Pharmaceuticals | 8/14/2012 | +20.65 |
| ECYT | Endocyte, Inc. | 9/28/2012 | +16.19 |
| CLVS | Clovis Oncology | 11/12/2012 | +15.75 |
| NVGN | Novogen Limited (ADR) | 4/3/2013 | +15.73 |
| PIP | PharmAthene, Inc. | 11/16/2010 | +15.27 |
| SRPT | Sarepta Therapeutics | 4/3/2013 | +14.90 |
| VVUS | VIVUS, Inc. | 2/23/2012 | +14.39 |
| KERX | Keryx Biopharmaceuticals | 1/29/2013 | +14.12 |
| YONG | Yongye Biotechnology International | 9/17/2010 | +13.88 |
| ALXN | Alexion Pharmaceuticals, Inc. | 10/19/2012 | +11.79 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 2/24/2012 | +11.53 |
| PCYC | Pharmacyclics, Inc. | 10/22/2012 | +11.03 |
| VRTX | Vertex Pharmaceuticals, Inc. | 4/19/2013 | +10.74 |
| THLD | Threshold Pharmaceuticals, Inc. | 3/20/2012 | +10.46 |
| IMUC | ImmunoCellular Therapeutics, Ltd. | 3/1/2012 | +10.22 |
| ACHN | Achillion Pharmaceuticals, Inc. | 10/19/2012 | +9.84 |
| CHTP | Chelsea Therapeutics International Ltd. | 9/20/2010 | +9.32 |
| AFFY | Affymax, Inc. | 10/19/2012 | +8.99 |
| ACAD | ACADIA Pharmaceuticals, Inc. | 3/21/2013 | +8.98 |
| STEM | StemCells, Inc. | 2/12/2013 | +8.82 |
| ONTY | Oncothyreon, Inc. | 12/19/2012 | +8.56 |
| ECYT | Endocyte, Inc. | 1/31/2013 | +8.15 |
| REGN | Regeneron Pharmaceuticals, Inc. | 2/16/2012 | +7.73 |
| CBST | Cubist Pharmaceuticals, Inc. | 3/8/2013 | +7.13 |
| ZIOP | ZIOPHARM Oncology | 10/19/2012 | +6.97 |
| PCYC | Pharmacyclics, Inc. | 3/25/2013 | +6.32 |
| NVGN | Novogen Limited (ADR) | 2/19/2013 | +5.93 |
| SGEN | Seattle Genetics, Inc. | 9/27/2010 | +5.83 |
| JAZZ | Jazz Pharmaceuticals, Inc. | 3/28/2012 | +5.24 |
| EXAS | EXACT Sciences Corp | 9/27/2010 | +3.77 |
| GERN | Geron Corp | 9/13/2010 | +3.18 |
| ITMN | InterMune, Inc. | 10/7/2010 | +2.54 |
| ANTH | Anthera Pharmaceuticals Inc | 9/24/2010 | +2.37 |
| QCOR | Questcor Pharmaceuticals | 9/9/2010 | +0.49 |
| MON | Monsanto Company | 8/14/2012 | -8.62 |
| SRPT | Sarepta Therapeutics | 5/2/2013 | -8.77 |
| AEZS | Aeterna Zentaris Inc | 4/5/2013 | -10.64 |
| ACAD | ACADIA Pharmaceuticals, Inc. | 4/11/2013 | -15.73 |
| MDVN | Medivation, Inc. | 2/28/2012 | -19.85 |
| QCOR | Questcor Pharmaceuticals | 9/24/2012 | -74.29 |
Metals and Mining
43 Outperform
20 Underperform
Oil, Gas and Consumable Fuels
24 Outperform
14 Underperform
Internet Software and Services
15 Outperform
6 Underperform
Pharmaceuticals
5 Outperform
15 Underperform
Hotels, Restaurants and Leisure
8 Outperform
11 Underperform
Electrical Equipment
10 Outperform
7 Underperform
Diversified Financial Services
7 Outperform
10 Underperform
Software
10 Outperform
7 Underperform
Food Products
9 Outperform
7 Underperform
Machinery
9 Outperform
6 Underperform
Household Durables
3 Outperform
7 Underperform
Energy Equipment and Services
6 Outperform
4 Underperform
Communications Equipment
4 Outperform
5 Underperform
Financial Services Funds
5 Outperform
4 Underperform
Textiles, Apparel and Luxury Goods
3 Outperform
5 Underperform
Internet and Catalog Retail
2 Outperform
6 Underperform
Specialty Retail
3 Outperform
4 Underperform
Chemicals
2 Outperform
5 Underperform
Media
2 Outperform
5 Underperform
Computers and Peripherals
4 Outperform
3 Underperform
Road and Rail
1 Outperform
5 Underperform
Diversified Consumer Services
3 Outperform
3 Underperform
Beverages
3 Outperform
2 Underperform
Electronic Equipment, Instruments and Components
2 Outperform
2 Underperform
Personal Products
0 Outperform
4 Underperform
Healthcare Equipment and Supplies
2 Outperform
2 Underperform
Diversified Leverage Funds
1 Outperform
3 Underperform
Leisure Equipment and Products
2 Outperform
2 Underperform
Natural Resources Funds
1 Outperform
3 Underperform
Capital Markets
3 Outperform
0 Underperform
Life Sciences Tools and Services
1 Outperform
2 Underperform
Food and Staples Retailing
2 Outperform
1 Underperform
Airlines
1 Outperform
1 Underperform
Gold Oriented Funds
1 Outperform
1 Underperform
Real Estate Management and Development
1 Outperform
0 Underperform
Diversified Telecommunication Services
1 Outperform
0 Underperform
Multi-Utilities
1 Outperform
0 Underperform
Consumer Services Funds
0 Outperform
1 Underperform
Tobacco
1 Outperform
0 Underperform












RSS Headlines
Fool UK